Skip to main content
SpringerLink
Log in

Atrial Fibrillation and Supraventricular Tachycardias

  • Chapter
  • First Online:
Evidence-Based Cardiology Consult

  • 1959 Accesses

Abstract

Atrial fibrillation (AF) can cause significant symptoms and diminished quality of life, but, more importantly, is associated with increased risks of stroke, congestive heart failure, and mortality. It is the most common arrhythmia, and its prevalence continues to increase. Its prevalence in 2005 was 3.03 million and is projected to rise to 7.56 million by 2050. Already AF accounts for 350,000 annual hospitalizations and $6.65 billion dollars in annual healthcare costs in the United States. The medical management of atrial fibrillation can be challenging and needs to encompass evaluation and treatment of underlying causes, thromboembolic prophylaxis, and decision-making regarding rate or rhythm control.

Supraventricular tachycardia (SVT) is a term that encompasses atrioventricular nodal reentrant tachycardia (AVNRT), atrioventricular reentrant tachycardia (AVRT), atrial tachycardia (AT), and inappropriate sinus tachycardia (IST). Although these disorders are generally considered benign, they can cause significant morbidity. In certain instances (Wolff-Parkinson-White syndrome), they can be life-threatening, and almost all tachyarrhythmias, if left untreated for extended periods of time, can lead to tachycardia-mediated cardiomyopathies. The prognostic implications for the patient, subsequent evaluation, and treatment may vary considerably depending on the etiology of the arrhythmia. The aim of this chapter is to provide a framework to successfully diagnose and manage these arrhythmias.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 209.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22(8):983–8.

    Article  PubMed  CAS  Google Scholar 

  2. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and the rationale for therapy. Am J Cardiol. 2003;91(6A):2D–88.

    Article  PubMed  Google Scholar 

  3. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham study. Circulation. 1998;98:946–52.

    Article  PubMed  CAS  Google Scholar 

  4. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009;104(11):1534–9.

    Article  PubMed  Google Scholar 

  5. Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, Zimetbaum P. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health. 2006;9(5):348–56.

    Article  PubMed  Google Scholar 

  6. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol. 1997;29(4):709–15.

    Article  PubMed  CAS  Google Scholar 

  7. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659–66.

    Article  PubMed  CAS  Google Scholar 

  8. Thijssen VL, Ausma J, Liu GS, Allessie MA, Van Eys GH, Borgers M. Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc Pathol. 2000;9(1):17–28.

    Article  PubMed  CAS  Google Scholar 

  9. Shen MJ, Choi EK, Tan AY, Lin SF, Fishbein MC, Chen LS, Chen PS. Neural mechanisms of atrial arrhythmias. Nat Rev Cardiol. 2011;9(1):30–9.

    Article  PubMed  Google Scholar 

  10. Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definition, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm. 2012;9(4):632–96.

    Article  PubMed  Google Scholar 

  11. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864–70.

    Article  PubMed  CAS  Google Scholar 

  12. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. J Am Coll Cardiol. 2000;35(1):183–7.

    Article  PubMed  CAS  Google Scholar 

  13. Hart RG, Pearce LA, Aguilar MI. Meta analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857–67.

    Article  PubMed  Google Scholar 

  14. Van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA. 2002;288(19):2441–8.

    Article  PubMed  Google Scholar 

  15. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2006;48:e149–246.

    Article  Google Scholar 

  16. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360–420.

    Article  PubMed  Google Scholar 

  17. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–51.

    Article  PubMed  CAS  Google Scholar 

  18. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883–91.

    Article  PubMed  CAS  Google Scholar 

  19. Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981–92.

    Article  PubMed  CAS  Google Scholar 

  20. Nagarakanti R, Ezekowitz MD, Oldgren J, et al. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion. Circulation. 2011;123(2):131–6.

    Article  PubMed  CAS  Google Scholar 

  21. Van Gelder IC, Groenveld HF, Crijns HJ, et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010;362(15):1363–73.

    Article  PubMed  Google Scholar 

  22. Doshi RN, Daoud EG, Fellows C, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol. 2005;16(11):1160–5.

    Article  PubMed  Google Scholar 

  23. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324(12):781–8.

    Article  PubMed  CAS  Google Scholar 

  24. Kober L, Torp-Pedersen C, McMurray JJ, et al. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med. 2008;358(25):2678–87.

    Article  PubMed  Google Scholar 

  25. Connolly SJ, Camm AJ, Halperin JL, et al. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med. 2011;365(24):2268–76.

    Article  PubMed  CAS  Google Scholar 

  26. Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA. 2007;298(11):1312–22.

    Article  PubMed  CAS  Google Scholar 

  27. Wyse DG, Waldo A, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347(23):1825–33.

    Article  PubMed  CAS  Google Scholar 

  28. Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358(25):2667–77.

    Article  PubMed  CAS  Google Scholar 

  29. Corley SD, Epstein AE, DiMarco JP. Relationships between sinus rhythm, treatment and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation. 2004;109(12):1509–13.

    Article  PubMed  Google Scholar 

  30. Pederson OD, Bagger H, Keller N, Marchant B, Kober L, Torp-Pedersen C. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation. 2001;104(3):292–6.

    Article  Google Scholar 

  31. Bonanno C, Paccanaro M, La Vecchia L, Ometto R, Fontanelli A. Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials. J Cardiovasc Med. 2010;11(6):408–18.

    Article  Google Scholar 

  32. Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32–8.

    Article  PubMed  Google Scholar 

  33. Hsu LF, Jais P, Sanders P, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med. 2004;351(23):2373–83.

    Article  PubMed  CAS  Google Scholar 

  34. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001;135:1061–73.

    Article  PubMed  CAS  Google Scholar 

  35. Kowey PR, Stebbins D, Igidbashian L, et al. Clinical outcome of patients who develop PAF after CABG surgery. Pacing Clin Electrophysiol. 2001;24:191–3.

    Article  PubMed  CAS  Google Scholar 

  36. Villareal RP, Hariharan R, Liu BC, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004;43(5):742–8.

    Article  PubMed  Google Scholar 

  37. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291(14):1720–9.

    Article  PubMed  CAS  Google Scholar 

  38. Patti G, Chello M, Candura D, Pasceri V, D’Ambrosio A, Covino E, Di Sciascio G. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia after cardiac surgery) study. Circulation. 2006;114(14):1455–61.

    Article  PubMed  CAS  Google Scholar 

  39. Imazio M, Brucato A, Ferrazzi P, et al. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011;124(21):2290–5.

    Article  PubMed  CAS  Google Scholar 

  40. Crystal E, Garfinkle MS, Connolly SS, Ginger TT, Sleik K, Yusuf SS. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2004;4, CD003611.

    PubMed  Google Scholar 

  41. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993;56(3):539–49.

    Article  PubMed  CAS  Google Scholar 

  42. Perez FJ, Schubert CM, Parvez B, Pathak V, Ellenbogen KA, Wood MA. Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis. Circ Arrhythm Electrophysiol. 2009;2(4):393–401.

    Article  PubMed  Google Scholar 

  43. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias – executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias developed in collaboration with NASPE-Heart Rhythm Society). J Am Coll Cardiol. 2003;42(8):1493–531.

    Article  PubMed  Google Scholar 

  44. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of electrocardiographic preexcitation in men. The Manitoba follow-up study. Ann Intern Med. 1992;116(6):456–60.

    Article  PubMed  CAS  Google Scholar 

  45. Calkins H, Yong P, Miller JM, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. Circulation. 1999;99(2):262–70.

    Article  PubMed  CAS  Google Scholar 

  46. Klein GJ, Gula LJ, Krahn AD, Skanes AC, Yee R. WPW pattern in the asymptomatic individual: has anything changed? Circulation. 2009;2:97–9.

    PubMed  Google Scholar 

  47. Wellens HJ. Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram. Circulation. 2005;112(14):210–7.

    Article  Google Scholar 

  48. Calo L, Rebecchi M, Sette A, et al. Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia. Heart Rhythm. 2010;7(9):1318–23.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiac Arrhythmia Consult Service, Department of Medicine, Stony Brook University School of Medicine, HSC 16-080, Stony Brook, NY, 11794, USA

    Roger Fan MD

  2. Cardiac Electrophysiology, Department of Medicine, Stony Brook University School of Medicine, HSC 16-080, Stony Brook, NY, 11794, USA

    Eric J. Rashba MD

Authors
  1. Roger Fan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric J. Rashba MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roger Fan MD .

Editor information

Editors and Affiliations

  1. Division of Cardiology, Department of Medicine,, Stony Brook University, School of Medicine,, Stony Brook, USA

    Kathleen Stergiopoulos

  2. Division of Cardiology, Stony Brook University, Stony Brook, New York, USA

    David L. Brown

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Fan, R., Rashba, E.J. (2014). Atrial Fibrillation and Supraventricular Tachycardias. In: Stergiopoulos, K., Brown, D. (eds) Evidence-Based Cardiology Consult. Springer, London. https://doi.org/10.1007/978-1-4471-4441-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4441-0_8

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4440-3

  • Online ISBN: 978-1-4471-4441-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation